236 related articles for article (PubMed ID: 33965767)
21. Low-Level Environmental Phthalate Exposure Associates with Urine Metabolome Alteration in a Chinese Male Cohort.
Zhang J; Liu L; Wang X; Huang Q; Tian M; Shen H
Environ Sci Technol; 2016 Jun; 50(11):5953-60. PubMed ID: 27138838
[TBL] [Abstract][Full Text] [Related]
22. Serum untargeted metabolomics analysis of the mechanisms of evodiamine on type 2 diabetes mellitus model rats.
Yu Y; Lu Q; Chen F; Wang S; Niu C; Liao J; Wang H; Chen F
Food Funct; 2022 Jun; 13(12):6623-6635. PubMed ID: 35635367
[TBL] [Abstract][Full Text] [Related]
23. Unveiling novel metabolic alterations in postmenopausal osteoporosis and type 2 diabetes mellitus through NMR-based metabolomics: A pioneering approach for identifying early diagnostic markers.
Kaur S; Kumari P; Singh G; Joshi N; Kaur T; Dhiman V; Singh G; Sachdeva N; Kumar D; Barnwal RP; Bhadada SK
J Proteomics; 2024 Jun; 302():105200. PubMed ID: 38772440
[TBL] [Abstract][Full Text] [Related]
24. Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus.
Wang C; Yu J; Zhang R; Wang W; Shi Z; Liu Y; Song G; Wang H; Han N; Huang L; An Y; Tian S; Chen Z
J Proteomics; 2020 Jul; 223():103823. PubMed ID: 32428569
[TBL] [Abstract][Full Text] [Related]
25. Phthalates and phthalate metabolites in urine from Tianjin and implications for platelet mitochondrial DNA methylation.
Li W; Guo L; Fang J; Zhao L; Song S; Fang T; Li C; Wang L; Li P
Front Public Health; 2023; 11():1108555. PubMed ID: 37181721
[TBL] [Abstract][Full Text] [Related]
26. Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study.
Piecha R; Svačina Š; Malý M; Vrbík K; Lacinová Z; Haluzík M; Pavloušková J; Vavrouš A; Matějková D; Müllerová D; Mráz M; Matoulek M
Cent Eur J Public Health; 2016 Dec; 24(4):297-301. PubMed ID: 28095285
[TBL] [Abstract][Full Text] [Related]
27. Association between environmental phthalates exposure and gut microbiota and metabolome in dementia with Lewy bodies.
Deng Z; Li L; Jing Z; Luo X; Yu F; Zeng W; Bi W; Zou J
Environ Int; 2024 Jun; 190():108806. PubMed ID: 38908272
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
[TBL] [Abstract][Full Text] [Related]
29. Contribution of phthalates and phthalate monoesters from drinking water to daily intakes for the general population.
Ding M; Kang Q; Zhang S; Zhao F; Mu D; Zhang H; Yang M; Hu J
Chemosphere; 2019 Aug; 229():125-131. PubMed ID: 31078027
[TBL] [Abstract][Full Text] [Related]
30. First Trimester Urinary Bisphenol and Phthalate Concentrations and Time to Pregnancy: A Population-Based Cohort Analysis.
Philips EM; Kahn LG; Jaddoe VWV; Shao Y; Asimakopoulos AG; Kannan K; Steegers EAP; Trasande L
J Clin Endocrinol Metab; 2018 Sep; 103(9):3540-3547. PubMed ID: 30016447
[TBL] [Abstract][Full Text] [Related]
31. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X
Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504
[TBL] [Abstract][Full Text] [Related]
32. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
33. LC/MS-Based Untargeted Metabolomics Analysis in Women with Morbid Obesity and Associated Type 2 Diabetes Mellitus.
Auguet T; Bertran L; Capellades J; Abelló S; Aguilar C; Sabench F; Del Castillo D; Correig X; Yanes O; Richart C
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175468
[TBL] [Abstract][Full Text] [Related]
34. Metabolomic Markers of Phthalate Exposure in Plasma and Urine of Pregnant Women.
Zhou M; Ford B; Lee D; Tindula G; Huen K; Tran V; Bradman A; Gunier R; Eskenazi B; Nomura DK; Holland N
Front Public Health; 2018; 6():298. PubMed ID: 30406068
[TBL] [Abstract][Full Text] [Related]
35. Phthalates might interfere with testicular function by reducing testosterone and insulin-like factor 3 levels.
Chang WH; Li SS; Wu MH; Pan HA; Lee CC
Hum Reprod; 2015 Nov; 30(11):2658-70. PubMed ID: 26385792
[TBL] [Abstract][Full Text] [Related]
36. Association of serum phthalates exposure with incident type 2 diabetes risk in Chinese population: A nested case-control study.
Zhang S; Cheng X; Jia C; An J; Zhang X; Li P; Guan Y; Yan Y; Zhao Z; Liu Y; Jing T; He M
Ecotoxicol Environ Saf; 2023 Oct; 265():115493. PubMed ID: 37729699
[TBL] [Abstract][Full Text] [Related]
37. Metabolomics and correlation network analyses of core biomarkers in type 2 diabetes.
Lin W; Wang M; Chen M; Zheng X; Wu Y; Gao D; Yang Z; Tian Z
Amino Acids; 2020 Sep; 52(9):1307-1317. PubMed ID: 32930872
[TBL] [Abstract][Full Text] [Related]
38. Maternal bisphenol and phthalate urine concentrations and weight gain during pregnancy.
Philips EM; Santos S; Steegers EAP; Asimakopoulos AG; Kannan K; Trasande L; Jaddoe VWV
Environ Int; 2020 Feb; 135():105342. PubMed ID: 31864031
[TBL] [Abstract][Full Text] [Related]
39. Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus.
Gu X; Al Dubayee M; Alshahrani A; Masood A; Benabdelkamel H; Zahra M; Li L; Abdel Rahman AM; Aljada A
Front Mol Biosci; 2020; 7():609806. PubMed ID: 33381523
[TBL] [Abstract][Full Text] [Related]
40. Is there an optimal sampling time and number of samples for assessing exposure to fast elimination endocrine disruptors with urinary biomarkers?
Faÿs F; Palazzi P; Hardy EM; Schaeffer C; Phillipat C; Zeimet E; Vaillant M; Beausoleil C; Rousselle C; Slama R; Appenzeller BMR
Sci Total Environ; 2020 Dec; 747():141185. PubMed ID: 32771784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
